期刊文献+

基质金属蛋白酶9与原发性高血压患者血压昼夜节律的相关性分析 被引量:1

Relationship between matrix metalloproteinases-9 and circadian rhythm of blood pressure in patients with essential hypertension
下载PDF
导出
摘要 目的探讨原发性高血压(EH)患者血清基质金属蛋白酶9(MMP-9)与血压昼夜节律模式改变的相关性。方法随机选择老年原发性高血压患者80例,其中杓型血压组27例作为对照,非杓型血压组27例、反杓型血压组26例作为研究对象,采用酶联免疫吸附试验法分别测定三组患者血清MMP-9水平,并进行对比分析。结果非杓型血压组、反杓型血压组患者的血清MMP-9水平高于对照组,差异有统计学意义(P<0.01,t=3.997、2.798),MMP-9与患者年龄、平均脉搏、入院收缩压、入院舒张压等基本临床资料无显著相关性(P>0.05)。结论非杓型血压组、反杓型血压组患者血清MMP-9表达增加,较杓型血压组患者发生心血管疾病损害的危险性增加,非杓型血压组与反杓型血压组患者血清MMP-9表达差异无统计学意义。 Objective To observe the relationship between the serum level of matrix metalloproteinase -9 ( MMP - 9) and circadian rhythm of ambulatory blood pressure in patients with essential hypertension. Methods According to ambulatory blood pressure, 80 patients with essential hypertension were divided into three groups: dipper group ( n = 27 ), non - dipper group ( n = 27 ), reversed - dipper group ( n = 26). The serum levels of MMP - 9 were detected by ELISA method in 80 senile hypertensive patients. Results The hypertension patiems in non - dipper group and reversed - dipper group exhibited higher levels of MMP - 9 (P 〈 0.01 ) than in the dipper group. The serum level of MMP - 9 was not significantly and positively eorrelated with HDL - C, LDL - C, age, and so on. Conclusion There exists the development of cardiovascular diseases in abnormal diurnal rhythm of blood pressure in essemial hypertension.
出处 《海南医学》 CAS 2010年第15期6-8,共3页 Hainan Medical Journal
关键词 原发性高血压 基质金属蛋白酶9 血压昼夜节律 Essential hypertension Matrix metalloproteinase Blood Pressure Circadian Rhythm
  • 相关文献

参考文献8

  • 1Gasanov AG,Bershova TV.The role of changes of matrix metalloproteinase in cardiovascular diseases[J].Biomed Khim,2009,55(2):155-168.
  • 2Berk BC,Fujiwara K,Lehoux S.ECM remodeling in hypertensive heart disease[J].J Clin Invest,2007,117:568-575.
  • 3Papazafiropoulou A,Tentolouris N.Matrix metalloproteinases and cardiovascular diseases[J].Hippokratia,2009,13(2):76-82.
  • 4Dhingra R,Pencina MJ,Peter Schrader,et al.Relations of matrix remodeling biomarkers to blood pressure progression and incidence of hypertension in the community[J].Circulation,2009,119(8):1 101-1 107.
  • 5Johan Sundstrom JC,Evans JD,Benjamin EJ,et al.Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures:The Framingham Heart Study[J].Circulation,2004,109(23):2 850-2 856.
  • 6Flamant M,Placier S,Dubroca C,et al.Role of matrix metalloproteinases in early hypertensive vascular remodeling[J].Hypertension,2007,50(1):212-218.
  • 7Céline Bouvet,Simon Moreau,Joannie Blanchette,et al.Sequential Activation of Matrix Metalloproteinase 9 and Transforming Growth Factor-β in Arterial Elastocalcinosis[J].Arterioscler Thromb Vasc Biol,2008,28:856-862.
  • 8Solini A,Santini E,Passaro A,et al.Family history of hypertension,anthropometric parameters and markers of early atherosclerosis in young healthy individuals[J].J Hum Hypertens,2009,23(12):801-807.

同被引文献5

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部